The neurological biomarkers market is expanding as neurological disorders, including dementia and Parkinson’s disease, become more prevalent with an aging global population. Innovations in biomarker discovery, particularly in genomics and imaging, are improving diagnostic precision and…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.